APA

Jakubikova J., Adamia S., Kost-Alimova M., Klippel S., Cervi D., Daley J. F., Cholujova D., Kong S., Leiba M., Blotta S., Ooi M., Delmore J., Laubach J., Richardson P. G., Sedlak J., Anderson K. C. & Mitsiades C. S. (20110630). Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. : Blood.

Chicago

Jakubikova Jana, Adamia Sophia, Kost-Alimova Maria, Klippel Steffen, Cervi David, Daley John F, Cholujova Dana, Kong Sun-Young, Leiba Merav, Blotta Simona, Ooi Melissa, Delmore Jake, Laubach Jacob, Richardson Paul G, Sedlak Jan, Anderson Kenneth C and Mitsiades Constantine S. 20110630. Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. : Blood.

Harvard

Jakubikova J., Adamia S., Kost-Alimova M., Klippel S., Cervi D., Daley J. F., Cholujova D., Kong S., Leiba M., Blotta S., Ooi M., Delmore J., Laubach J., Richardson P. G., Sedlak J., Anderson K. C. and Mitsiades C. S. (20110630). Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. : Blood.

MLA

Jakubikova Jana, Adamia Sophia, Kost-Alimova Maria, Klippel Steffen, Cervi David, Daley John F, Cholujova Dana, Kong Sun-Young, Leiba Merav, Blotta Simona, Ooi Melissa, Delmore Jake, Laubach Jacob, Richardson Paul G, Sedlak Jan, Anderson Kenneth C and Mitsiades Constantine S. Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. : Blood. 20110630.